Evidence map›Paper›PMID 36204275›Full record

ArticleiScience2022

UL49 is an essential subunit of the viral pre-initiation complex that regulates human cytomegalovirus gene transcription.

Declan L Turner, Svenja Fritzlar, Sara Sadeghipour, Adele A Barugahare, Brendan E Russ, Stephen J Turner, Rommel A Mathias

Open access · goldAbstract read
In one paragraph

Article in iScience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. A pan-cancer atlas of therapeutic T cell targets.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Declan L TurnerInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Department of Microbiology, Monash University, 23 Innovation Walk, Clayton, VIC 3800, Australia.
Svenja FritzlarInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Department of Microbiology, Monash University, 23 Innovation Walk, Clayton, VIC 3800, Australia.
Sara SadeghipourInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Department of Microbiology, Monash University, 23 Innovation Walk, Clayton, VIC 3800, Australia.
Adele A BarugahareInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Department of Microbiology, Monash University, 23 Innovation Walk, Clayton, VIC 3800, Australia.
Brendan E RussInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Department of Microbiology, Monash University, 23 Innovation Walk, Clayton, VIC 3800, Australia.
Stephen J TurnerInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Department of Microbiology, Monash University, 23 Innovation Walk, Clayton, VIC 3800, Australia.
Rommel A MathiasInfection and Immunity Program, Monash Biomedicine Discovery Institute, and Department of Microbiology, Monash University, 23 Innovation Walk, Clayton, VIC 3800, Australia.
Australian Regenerative Medicine Institute · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

More than half the world's population is infected with human cytomegalovirus (HCMV), causing congenital birth defects and impacting the immuno-compromised. Many of the >170 HCMV genes remain uncharacterized, and this gap in knowledge limits the development of novel antivirals. In this study, we investigated the essential viral protein UL49 and found it displayed leaky late expression kinetics, and localized to nuclear replication compartments. Cells infected with mutant UL49 virus were unable to produce infectious virions and phenocopied other beta-gamma viral pre-initiation complex (vPIC) subunit (UL79, UL87, UL91, UL92, and UL95) mutant infections. RNA-seq analysis of vPIC mutant infections revealed a consistent diminution of genes encoding capsid subunits, including TRX2/UL85 and MCP/UL86, envelope glycoproteins gM, gL and gO, and egress-associated tegument proteins UL99 and UL103. Therefore, as a member of the vPIC, UL49 serves as a fundamental HCMV effector that governs viral gene transcription required to complete the replication cycle.

Indexed as

Molecular biologytranscriptomicsvirology

Identifiers

PMID36204275
PMCPMC9530030
OpenAlexW4296381475

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.